Atea Pharmaceuticals reported total assets of $232.28M and total liabilities of $28.12M for the quarter ended Jun 2026, down 40.7% year over year. This balance sheet covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 0.16M | 0.27M | 0.69M | 1.10M | 1.52M | |||||||||||||||||||||||
| Assets | ||||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 839.66M | 764.38M | 705.54M | 684.48M | 176.41M | 188.46M | 183.25M | 213.70M | 594.88M | 143.82M | 539.19M | 494.71M | 474.99M | 451.01M | 421.88M | 368.89M | 77.34M | 95.71M | 79.32M | 76.55M | ||||||||
| Receivables - NetNet Receivables | 4.51M | |||||||||||||||||||||||||||
| Receivables - OtherOther Receivables | ||||||||||||||||||||||||||||
| Receivables | 4.51M | |||||||||||||||||||||||||||
| Prepaid Assets | 3.29M | 8.03M | 7.69M | 4.97M | 12.45M | 14.21M | 11.90M | 12.76M | 8.19M | 12.35M | 7.27M | 4.16M | 4.09M | 7.63M | 8.27M | 5.89M | 6.83M | 9.16M | 7.19M | 9.20M | ||||||||
| Current Assets | 842.95M | 772.40M | 713.23M | 689.45M | 681.93M | 660.92M | 632.39M | 620.83M | 603.32M | 590.46M | 548.76M | 506.37M | 486.91M | 462.36M | 433.71M | 385.60M | 336.14M | 310.99M | 263.20M | 228.66M | ||||||||
| Non-Current Assets | ||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 0.03M | 0.02M | 0.76M | 1.90M | 1.81M | 1.71M | 1.60M | 1.50M | 1.39M | 1.29M | 1.19M | 1.08M | 0.98M | 0.87M | 0.77M | 0.67M | 0.56M | 0.46M | 0.35M | 0.25M | ||||||||
| Other Non-Current Assets | 0.30M | 0.30M | 0.30M | 0.30M | 0.30M | 1.49M | 0.20M | 0.20M | 1.40M | 1.40M | 1.40M | 1.40M | 1.68M | 0.20M | 4.39M | 4.39M | 5.47M | 3.14M | 3.05M | 3.05M | ||||||||
| Non-Current Assets | 0.56M | 0.49M | 3.96M | 4.89M | 4.64M | 5.79M | 5.74M | 5.20M | 4.76M | 4.51M | 4.26M | 4.01M | 4.05M | 2.31M | 6.26M | 6.00M | 6.83M | 4.23M | 3.88M | 3.62M | ||||||||
| Assets | 843.50M | 772.89M | 717.19M | 694.34M | 686.58M | 666.71M | 638.13M | 626.03M | 608.08M | 594.97M | 553.03M | 510.38M | 490.96M | 464.67M | 439.96M | 391.61M | 342.96M | 315.22M | 267.08M | 232.28M | ||||||||
| Liabilities | ||||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||||
| Accounts Payables | 22.19M | 4.53M | 3.66M | 13.88M | 1.12M | 2.55M | 0.70M | 3.96M | 0.40M | 4.25M | 21.14M | 5.47M | 5.79M | 4.46M | 7.39M | 8.84M | 3.52M | 12.95M | 9.45M | 10.06M | ||||||||
| Payables | 22.19M | 4.53M | 3.66M | 13.88M | 1.12M | 2.55M | 0.70M | 3.96M | 0.40M | 4.25M | 21.14M | 5.47M | 5.79M | 4.46M | 7.39M | 8.84M | 3.52M | 12.95M | 9.45M | 10.06M | ||||||||
| Accumulated Expenses | 47.68M | 52.15M | 24.84M | 10.49M | 13.80M | 15.21M | 10.93M | 11.46M | 17.75M | 27.36M | 19.41M | 20.37M | 18.61M | 13.35M | 13.55M | 10.45M | 15.83M | 26.00M | 23.29M | 17.64M | ||||||||
| Current Leases | 0.20M | 0.11M | 0.73M | 0.71M | 0.72M | 0.73M | 0.74M | 0.75M | 0.76M | 0.77M | 0.78M | 0.79M | 0.80M | 0.81M | 0.82M | 0.83M | 0.84M | 0.63M | 0.42M | |||||||||
| Current Taxes | 12.00M | 2.57M | 2.57M | 0.01M | 0.71M | 0.10M | 0.18M | 0.02M | ||||||||||||||||||||
| Current Deferred Revenue | 192.18M | |||||||||||||||||||||||||||
| Total Current Liabilities | 262.05M | 56.88M | 28.61M | 25.11M | 15.63M | 18.48M | 12.36M | 16.16M | 18.89M | 32.38M | 41.31M | 26.62M | 25.19M | 18.60M | 21.75M | 20.12M | 20.18M | 39.78M | 33.37M | 28.12M | ||||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||||
| Preferred Stock Liabilities | ||||||||||||||||||||||||||||
| Operating Leases | 2.76M | 2.77M | 2.58M | 2.40M | 2.21M | 2.03M | 1.83M | 1.64M | 1.45M | 1.25M | 1.04M | 0.84M | 0.63M | 0.42M | 0.21M | |||||||||||||
| Other Non-Current Liabilities | 5.93M | 5.93M | 6.01M | 5.17M | 5.25M | 5.37M | 5.49M | 5.62M | 5.76M | 5.90M | 6.05M | 6.20M | 6.36M | 6.50M | 6.64M | 6.79M | ||||||||||||
| Total Non-Current Liabilities | 56.88M | 31.37M | 27.87M | 18.22M | 20.88M | 14.58M | 18.18M | 20.73M | 34.02M | 42.76M | 27.86M | 26.23M | 19.45M | 22.38M | 20.54M | 20.39M | 39.78M | |||||||||||
| Total Liabilities | 262.05M | 62.81M | 37.30M | 33.88M | 23.39M | 26.14M | 19.95M | 23.68M | 26.34M | 39.78M | 48.66M | 33.91M | 32.44M | 25.80M | 28.88M | 27.19M | 27.18M | 39.78M | 33.37M | 28.12M | ||||||||
| Shareholder's Equity | ||||||||||||||||||||||||||||
| Common Equity | 581.45M | 710.08M | 679.88M | 660.46M | 663.19M | 640.57M | 618.18M | 602.35M | 581.73M | 555.19M | 504.37M | 476.47M | 458.52M | 438.87M | 411.08M | 364.42M | 315.78M | 275.43M | 233.71M | 204.16M | ||||||||
| Liabilities and Shareholders Equity | 843.50M | 772.89M | 717.19M | 694.34M | 686.58M | 666.71M | 638.13M | 626.03M | 608.08M | 594.97M | 553.03M | 510.38M | 490.96M | 464.67M | 439.96M | 391.61M | 342.96M | 315.22M | 267.08M | 232.28M | ||||||||
| Retained Earnings | 642.47M | 653.96M | 665.85M | 677.76M | 689.41M | 701.05M | 713.75M | 726.11M | 738.58M | 750.74M | 763.47M | 776.19M | 788.47M | 802.77M | 809.37M | 799.95M | 793.17M | 797.75M | 801.74M | 805.12M | ||||||||
| Treasury Shares |